Yuval Cohen insider trades: Corbus Pharmaceuticals Holdings (CRBP) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Yuval reports to the SEC
Open-market buys and sales
30 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | CRBP | ↓ Sell | 17,000 | $10.08 | $171K | Direct | Aug 10, 2026 (3d) |
| Feb 13, 2026 | CRBP | ↓ Sell | 13,871 | $7.78 | $108K | Direct | Feb 18, 2026 (5d) |
| Oct 27, 2025 | CRBP | ↓ Sell | 27,633 | $17.05 | $471K | Direct | Oct 27, 2025 (0d) |
| Feb 14, 2025 | CRBP | ↓ Sell | 7,134 | $8.76 | $62K | Direct | Feb 18, 2025 (4d) |
| Jun 18, 2024 | CRBP | ↓ Sell | 63,358 | $46.57 | $3.0M | Direct | Jun 18, 2024 (0d) |
| Aug 10, 2022 | CRBP | ↑ Buy | 3,800 | $0.26 | $1K | Direct | Aug 11, 2022 (1d) |
| May 16, 2022 | CRBP | ↑ Buy | 10,500 | $0.25 | $3K | Direct | May 16, 2022 (0d) |
| Mar 9, 2022 | CRBP | ↑ Buy | 8,600 | $0.37 | $3K | Direct | Mar 9, 2022 (0d) |
| Nov 11, 2020 | CRBP | ↑ Buy | 4,240 | $1.21 | $5K | Direct | Nov 12, 2020 (1d) |
| Mar 17, 2020 | CRBP | ↑ Buy | 4,300 | $3.49 | $15K | Direct | Mar 17, 2020 (0d) |
| Nov 12, 2019 | CRBP | ↑ Buy | 1,430 | $4.26 | $6K | Direct | Nov 12, 2019 (0d) |
| Aug 12, 2019 | CRBP | ↑ Buy | 1,175 | $6.06 | $7K | Direct | Aug 12, 2019 (0d) |
| May 13, 2019 | CRBP | ↑ Buy | 995 | $6.99 | $7K | Direct | May 14, 2019 (1d) |
| Mar 14, 2019 | CRBP | ↑ Buy | 1,530 | $6.49 | $10K | Direct | Mar 14, 2019 (0d) |
| May 15, 2018 | CRBP | ↑ Buy | 1,725 | $5.85 | $10K | Direct | May 16, 2018 (1d) |
| Mar 14, 2018 | CRBP | ↑ Buy | 1,160 | $6.88 | $8K | Direct | Mar 15, 2018 (1d) |
| Nov 10, 2017 | CRBP | ↑ Buy | 1,000 | $7.17 | $7K | Direct | Nov 13, 2017 (3d) |
| Aug 11, 2017 | CRBP | ↑ Buy | 1,695 | $6.00 | $10K | Direct | Aug 11, 2017 (0d) |
| May 11, 2017 | CRBP | ↑ Buy | 3,250 | $6.01 | $20K | Direct | May 12, 2017 (1d) |
| Nov 22, 2016 | CRBP | ↑ Buy | 1,340 | $7.64 | $10K | Direct | Nov 23, 2016 (1d) |
| Jun 6, 2016 | CRBP | ↑ Buy | 1,500 | $3.34 | $5K | Direct | Jun 7, 2016 (1d) |
| May 18, 2016 | CRBP | ↑ Buy | 2,125 | $2.40 | $5K | Direct | May 19, 2016 (1d) |
| Nov 23, 2015 | CRBP | ↑ Buy | 535 | $1.76 | $941 | Direct | Nov 24, 2015 (1d) |
| Nov 13, 2015 | CRBP | ↑ Buy | 850 | $1.73 | $1K | Direct | Nov 16, 2015 (3d) |
| Aug 24, 2015 | CRBP | ↑ Buy | 550 | $1.95 | $1K | Direct | Aug 25, 2015 (1d) |
| Aug 17, 2015 | CRBP | ↑ Buy | 2,100 | $1.92 | $4K | Direct | Aug 18, 2015 (1d) |
| Jun 15, 2015 | CRBP | ↑ Buy | 900 | $3.28 | $3K | Direct | Jun 15, 2015 (0d) |
| Dec 17, 2014 | CRBP | ↑ Buy | 400 | $3.66 | $1K | Direct | Dec 18, 2014 (1d) |
| Dec 4, 2014 | CRBP | ↑ Buy | 500 | $3.30 | $2K | Direct | Dec 4, 2014 (0d) |
| Dec 3, 2014 | CRBP | ↑ Buy | 1,000 | $3.20 | $3K | Direct | Dec 4, 2014 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRBP insiders
Open-market trades in the last 12 months
About Yuval Cohen's insider trades
Yuval Cohen is Chief Executive Officer at Corbus Pharmaceuticals Holdings (CRBP). Since Dec 3, 2014, Yuval has reported 25 open-market purchases worth $149K and 5 sales worth $3.8M on SEC Form 4. In the last 12 months: 2 sales ($279K).
Their filings also include grants and awards (12 filings), option exercises (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRBP insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.